The Scientific Advisory Board (SAB) of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program met in September to discuss the results of the HIV Prevention Trials Network (HPTN) 052 trial, which found that individuals with HIV infection who were given immediate antiretroviral therapy (ART) were 96 percent less likely to transmit the virus […]
The TB Alliance announced Tuesday that it has enlisted the help of the National Institute of Allergy and Infectious Diseases (NIAID) AIDS Clinical Trial Group (ACTG) to help complete testing of a potentially shorter tuberculosis treatment regimen utilizing an antibiotic not currently registered to treat TB – moxifloxacin.
Dr. Mean Chhi Vun, director of Cambodia’s National Center for HIV/AIDS, Dermatology and STDs (NCHADS), offered an exciting progress report to the TB/HIV Working Group of the Stop TB Partnership at their meeting last week in Beijing, including representatives from tuberculosis (TB) and HIV programs in China and elsewhere in the Pacific region…
HIV
The U.S. Department of State today issued an expression of concern over Tanzanian government actions targeting its LGBT population, noting that the violence, oppression and intimidation […]
Tuberculosis
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
Two years after launching surveillance of acute flaccid myelitis, and amid climbing cases, CDC continues to seek cause, and notes gaps in knowledge of long term […]